Track A     Basic and Clinical Sciences
Since the discovery of HIV in 1983, properties of the virus have been elucidated with unprecedented speed. Around 1995, combined outcomes of basic and clinical sciences revealed crucial findings such as the relentless growth of HIV throughout the course of the infection, half-lives of the infected cells in individuals, correlation of viral load and patient prognosis, etc. The advent of HAART around the same time helped to create an "eradication paradigm" and its idea was condensed in a slogan, "hit early and hard". In less than 10 years it has turned out that the eradication is not an easy task. Serious "new" problems such as long-term toxicities of antiretroviral drugs (ARVs), drug resistant viruses, and rapidly growing epidemics of subtype C HIV in certain areas of the world are accumulating. Despite a human dream over 20 years to invent effective vaccines, HIV has kept turning down our efforts. Corresponding to "Treat 3 million by 2005 (3 by 5) Initiative" by WHO and UNAIDS, medical sciences must also respond to the needs of PLWHA in most parts of the world, especially in Asia and the Pacific region, where ARVs are largely unavailable. Developing simplified initial regimens together with feasible salvage, cheap but reliable surrogate markers and effective prevention of mother to child transmission in resource-poor settings are among the crucial issues. These considerations necessitate a continuous and accelerated focus on basic and clinical research.
Track A deals with a wide variety of topics in basic and clinical sciences such as virology, immunology, epidemiology, human genome science, treatment, clinical trials, prevention, drug discovery, drug resistance, adverse event, opportunistic infections, vaccine development, etc. Contributions with special emphasis on the particular characteristics in Asia and the Pacific are encouraged.


Track B     Treatment, Care and Support
Introduction of HAART dramatically improved the clinical features of HIV/AIDS and significantly decreased its death toll in developed countries. However, access to HAART has been greatly limited in a number of countries in Asia and the Pacific, and the majority of infected people in the region are still living with little or no medical care or support. Meanwhile, HIV infection is spreading at an alarming speed, generating significant medical, social, and economic impacts in a number of afflicted countries in the region. Assurance of access to medical interventions and preventive methods is the urgent priority issue. To overcome this issue, WHO and UNAIDS seek to facilitate the provision of HIV/AIDS treatment to three million people by the end of 2005 (3 by 5). 7th ICAAP is a good chance to evaluate progress of "3 by 5" in Asia and the Pacific.
Thus, Track B seeks to address issues related to both community responses and methods of treatment, care and support as well as clinical treatment of HIV infection in the region. Some key topics are: "3 by 5" in Asia and the Pacific, treatment options for minimizing side effects of HAART, palliative and terminal care, treatment, care and support in resource-limited settings, alternative therapies, creative and innovative treatment, care and support approaches at the community level and evaluation of treatment and care programs. This track should be of particular interest to investigators and clinicians and to community and NGO workers who care for and support PLWHAs in the region.


Track C     Prevention and Epidemiology
With a population of nearly 3.5 billion, Asia and the Pacific region has the potential for influencing the course and overall impact of the global HIV/AIDS pandemic. HIV epidemics in the region are diverse and fuelled through sexual networks and injection drug use. The need for swift preventive actions that strongly enhance regional ability to increase coverage/scale up responses to the epidemic is absolutely urgent.
However, several countries in the region have demonstrated effective initiatives in preventing the spread of the virus even in resource-limited conditions.
Track C focuses on trends, dynamics and impact of the HIV epidemic in the region. It also includes an in-depth understanding of HIV vulnerability through research and community-based interventions with diverse communities. This track also places a great emphasis on behavioral prevention efforts by public health workers, social scientists, NGOs, private sectors and community-based organizations and explores the prevention strategies that are effective and appropriate in the regional contexts or realities. Institutional prevention efforts and most recent advances in the biological prevention measures including an international partnership establishment for AIDS vaccine development will also be addressed.


Track D     Culture, Gender and Sexual Issues
Over two decades of fighting against the HIV/AIDS epidemic gave us three lessons in terms of gender and sexual issues. First, the inseparable connection between HIV/AIDS and various sexual issues, has been, is and will be the single most deeply rooted cause of stigma, discrimination and denial.
Second, the consideration of gender and the empowerment of women and children have been, are and will be the key to develop successful policies of prevention and care. Any policy and program cannot be effective without gender perspective. Although issues concerning gender and sexual matters cannot be magically resolved, they should be actively addressed and strategies must be developed to identify what make men and women vulnerable, to redefine gender roles and to cultivate healthier environment for all of us.
Third, in order to be effective, AIDS policies have to be intrinsically sensitive to cultural, religious and linguistic differences. In every aspect of developing AIDS program, involvement of key stake holders such as LGBT, drug users, sex workers, migrants and local community should be encouraged at local, national and regional level.
Track D has a special significance in Asia and the Pacific region, since no other region has more diversities in terms of culture, religion and language. Track D invites wide range of experiences in various communities and fruitful discussions.


Track E     Political, Economic and Social Contexts
Track E seeks to address (1) the social and economic impact of HIV/AIDS and (2) the political, social and economic interventions need to reduce HIV vulnerability and to improve prevention and access to treatment.
The powerful socio-economic effects of HIV/AIDS highlight the importance of governmental leadership and the coordination of national responses to HIV/AIDS (Three Ones) in Asia Pacific region. Concerning the development,
implementation and assessment of political and legal reforms require to produce fresher national, regional and international approaches. Moreover, to be effective, funding, resource mobilization and allocation should be carefully considered in the design of AIDS policies, including access to treatment. Sound and scientific understandings of larger social contexts, such as the effects of globalization, urbanization and industrialization, must ground such approaches.
Along with governmental leadership, effective and collaborative policies need the participation of NGOs and community-based organizations. This participation requires an active role of the media, the private sector, as well as multilateral organizations. The development and evaluation process of AIDS policies must involve PLWHA. In addition, vulnerable populations such as women, children, migrants, LGBT, sex workers and drug users have to play a key role in the process. At all levels, policies should guarantee the protection of human rights, in particular those of marginalized and vulnerable people. Such policies will help fight against stigma, discrimination and denial, as well as produce improved access to treatment, care, support and prevention.